The program seeks to develop the future leaders of clinical innovation by offering an opportunity to integrate pre-PhD, PhD and initial post-PhD research training with completion of vocational training of the highest standard. Bespoke and tailored towards the research direction of each successful candidate, MACH-Track is flexibly designed to adapt to any specialist college-accredited discipline.

“MACH-Track is a new program that allows promising recently-qualified doctors to integrate career development in research, including a PhD, with completion of postgraduate specialist or generalist training. This exciting new scheme is a pilot for medical workforce development that will ensure our nation has the research-active clinical innovators it needs to ensure a healthy future for all Australians.”

Professor Sir John Savill, MACH Executive Director 

Meet our successful MACH-Track trainees

We will be sharing the latest updates on their work in our newsletters, on twitter and on our website.

 

The next MACH-Track intake will begin in 2022 and run over 5 – 6 years:

Year 1: Pre-PhD start year of the program – 80% clinical (vocational) training / 20% PhD preparation

Years 2 – 4: PhD scholarship (2023 – 2025) – 80% PhD / 20% clinical role

Year 5: Post-PhD: 80% clinical (vocational) training / 20% preparation for post-doctoral fellowship application

Years 6 and 6+: As for Year 5 to completion of clinical (vocational) training and, ideally, a post-doctoral fellowship

MACH-Track scholarships will be awarded to five candidates who are undertaking training in any AMC recognised specialty including General Practice and Public Health. There will be additional opportunities for candidates with a specific interest in brain cancers and Parkinson’s Disease.

Any Australian Medical Council accredited specialist medical college training program leading to fellowship of the specialist medical college.
Specimen PhD Projects available:
To give applicants a flavour of the range of PhD opportunities available for candidates to consider during Year 1 of MACH-Track, here is a selection of projects that will be on offer. There will be a “taster” Year 1 mini-project available for each substantive 3-year PhD project:

Centre for Eye Research Australia

  • Satellite imaging to transform detection of diabetic retinopathy and other retinal vascular diseases
  • Repair of the cornea to restore vision: Translation to a Surgical Repair Device
  • Neuronal responses to mitochondrial DNA haplogroups.

Department of General Practice

  • Utilising technology to optimise the management of heart failure in primary care
  • The clinical utility of pharmacogenomic testing to inform antidepressant prescribing in primary care.

Florey Institute

  • Investigating the Role of Epigenetics in Multiple Sclerosis
  • Developing novel therapies to harness the progression of Multiple Sclerosis.

Murdoch Children’s Research Institute

  • Understanding disease mechanisms and outcomes in Australian children with acute stroke using sophisticated blood and neuroimaging biomarkers
  • Taking placenta to scale: The population burden of disordered placentation and placental function
  • Early life inflammation in non-communicable childhood disease.

National Ageing Research Institute

  • A tool for predicting prolonged grief in family carers of people living with dementia
  • Identifying elder abuse in medical settings
  • Enhancing 3D (dementia, delirium, depression) care for older people in residential care via micro-learning.

Olivia Newton-John Cancer Research Institute

  • Strategies to enhance the efficacy of targeted therapies in gastrointestinal cancers
  • a) Improving tyrosine kinase inhibitors-based therapies for metastatic Her2+ breast cancer
    b) Investigating the contribution of matrix/integrin signalling in breast cancer metastasis and therapy resistance
  • a) Deploying novel technologies to identify resistance mechanisms in patients with haematological malignancies receiving targeted therapies
    b) Identifying new strategies for minimum residual disease monitoring to optimise response assessment in myeloid & lymphoid malignancies.

Peter MacCallum Cancer Centre

  • Understanding the behaviour of cancer at single cell resolution
  • Improving management of infections in cancer
  • Clinical investigation of the immune response to radiotherapy and immunotherapy.

WEHI

  • Translational research into haematological malignancies
  • Utilising pre-clinical models to discover novel therapies for tuberculosis
  • Hyposplenism in coeliac disease.

For more information about these specialisations, contact Senior Project Officer– Meredith Bickley

  • The MACH-Track pathway is open to doctors training in any recognised medical specialty, including General Practice and Public Health. Applicants should have won a place in a Melbourne-centred vocational training program approved by the relevant Royal/Specialist College; for specialties with two-stage programs (eg physicians) trainees should have secured a place in an advanced training program.
  • Applicants must be currently in post in one of the ten MACH-affiliated health services, or be on a training rotation that will bring the candidate to a MACH-affiliated health service by February of the first year. General Practice trainees will require sponsorship by the University of Melbourne Department of General Practice.

 

The selection committee will base its assessment on the application form, applicant career aspiration, CV and referee reports.

Applications should be sent to [email protected] and must include:

  1. A letter of application no longer than 500 words explaining why the applicant wants to pursue PhD training through the MACH-Track, to include broad areas of research interest;
  2. Brief details of the candidate’s vocational training program, with dates and location of each attachment; proposed end date; and details of the relevant College training committee including email contact for the lead College administrator;
  3. Full CV, to include details of any research experience and how findings were reported or disseminated (e.g. abstract presentation at meeting);
  4. A brief letter of support from an academic referee able to comment on the candidate’s potential for completing a PhD;
  5. A brief letter from the candidate’s current clinical training supervisor confirming that the candidate is making satisfactory progress in vocational training and stating support for the candidate seeking flexibility in clinical training, if appointed.
    For General Practice trainees, a brief note from A/Prof Jo-Anne Manski-Nankervis confirming sponsorship by the University of Melbourne Department of General Practice.

Candidates short-listed for interview will be informed generally at the end of August.

Interviews will likely be held at the end of September ahead of a February start.

To be confirmed for 2023 intake.

End June: Applications open

Start August: Applications close at 5 PM (AEST)

End August: Invitations sent out to short-listed candidates for interviews

End September: Interviews are conducted

February: Successful applicants to start their MACH-Track journey

MACH-Track Co-Directors

The MACH-Track Co-Directors are:

Associate Professor Margie Danchin
MBBS PhD FRACP

Group Leader, Vaccine Uptake, Murdoch Children’s Research Institute; Paediatrician, Department of General Medicine,The Royal Children’s Hospital; A/Prof and David Bickart Clinician Scientist Fellow, Department of Paediatrics and School of Population and Global Health, The University of Melbourne; Director Clinician Scientist pathways, The University of Melbourne Chair, Collaboration on Social Science and Immunisation (COSSI).

Professor Mark Dawson
FAHMS MBBS; FRACP; FRCPA; PhD

Associate Director for Research Translation; Consultant Haematologist; Program Head, Cancer Biology & Therapeutics; Head, Cancer Epigenetics Laboratory, Peter MacCallum Cancer Centre.

Professor Kate Drummond AM

MBBS MD FRACS
Neurosurgeon; Director of Neurosurgery, RMH; Head of Central Nervous System Tumours, VCCC, Parkville Precinct.

Prof Hui K. Gan
MBBS, PhD, FRACP
Director, Cancer Clinical Trials Unit, Austin Health; Clinical Research Lead and Co-Director, Centre for Research Excellence in Brain Cancer Research, Olivia Newton-John Cancer Research Institute.

Associate Professor Jo-Anne Manski-Nankervis
BSc(Hons) MBBS(Hons) CHIA PhD FRACGP
Academic General Practitioner and Lead, Data Driven Quality Improvement Research Theme, Department of General Practice, University of Melbourne; Chair, RACGP Expert Committee – Research.